Royal Bank of Canada’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$770K Sell
23,164
-10,073
-30% -$335K ﹤0.01% 3809
2025
Q1
$973K Sell
33,237
-1,106
-3% -$32.4K ﹤0.01% 3199
2024
Q4
$1.13M Sell
34,343
-3,799
-10% -$125K ﹤0.01% 3043
2024
Q3
$1.69M Sell
38,142
-3,630
-9% -$161K ﹤0.01% 2760
2024
Q2
$1.8M Sell
41,772
-8,929
-18% -$385K ﹤0.01% 2685
2024
Q1
$1.48M Sell
50,701
-5,843
-10% -$171K ﹤0.01% 2799
2023
Q4
$1.26M Buy
56,544
+2,545
+5% +$56.7K ﹤0.01% 3020
2023
Q3
$1.34M Buy
53,999
+4,130
+8% +$102K ﹤0.01% 2782
2023
Q2
$1.41M Buy
49,869
+4,946
+11% +$140K ﹤0.01% 2756
2023
Q1
$1.03M Sell
44,923
-578
-1% -$13.3K ﹤0.01% 2993
2022
Q4
$1.28M Buy
45,501
+3,960
+10% +$111K ﹤0.01% 2898
2022
Q3
$1.18M Buy
41,541
+9,615
+30% +$272K ﹤0.01% 2899
2022
Q2
$708K Buy
31,926
+6,636
+26% +$147K ﹤0.01% 3377
2022
Q1
$735K Sell
25,290
-3,275
-11% -$95.2K ﹤0.01% 3502
2021
Q4
$940K Sell
28,565
-1,967
-6% -$64.7K ﹤0.01% 3408
2021
Q3
$1.41M Buy
30,532
+6,066
+25% +$280K ﹤0.01% 2956
2021
Q2
$1.35M Sell
24,466
-16,024
-40% -$883K ﹤0.01% 3025
2021
Q1
$2.09M Buy
40,490
+2,110
+5% +$109K ﹤0.01% 2596
2020
Q4
$1.66M Sell
38,380
-82,259
-68% -$3.56M ﹤0.01% 2657
2020
Q3
$4.22M Buy
120,639
+19,209
+19% +$672K ﹤0.01% 1839
2020
Q2
$5.43M Buy
101,430
+7,011
+7% +$375K ﹤0.01% 1664
2020
Q1
$3.35M Buy
94,419
+2,964
+3% +$105K ﹤0.01% 1815
2019
Q4
$4.37M Buy
91,455
+79,503
+665% +$3.8M ﹤0.01% 1892
2019
Q3
$388K Sell
11,952
-56,175
-82% -$1.82M ﹤0.01% 3470
2019
Q2
$3.4M Sell
68,127
-1,780
-3% -$88.8K ﹤0.01% 1988
2019
Q1
$4.71M Sell
69,907
-57,293
-45% -$3.86M ﹤0.01% 1736
2018
Q4
$5.87M Sell
127,200
-31,410
-20% -$1.45M ﹤0.01% 1529
2018
Q3
$12.2M Buy
158,610
+1,210
+0.8% +$93.3K 0.01% 1229
2018
Q2
$13.3M Sell
157,400
-113,148
-42% -$9.53M 0.01% 1144
2018
Q1
$22.1M Sell
270,548
-43,713
-14% -$3.57M 0.01% 876
2017
Q4
$18M Buy
314,261
+223,106
+245% +$12.8M 0.01% 987
2017
Q3
$6.08M Buy
91,155
+82,024
+898% +$5.47M ﹤0.01% 1520
2017
Q2
$470K Buy
9,131
+2,648
+41% +$136K ﹤0.01% 3078
2017
Q1
$378K Buy
6,483
+4,321
+200% +$252K ﹤0.01% 3276
2016
Q4
$90K Buy
2,162
+151
+8% +$6.29K ﹤0.01% 4187
2016
Q3
$106K Sell
2,011
-2,353
-54% -$124K ﹤0.01% 4059
2016
Q2
$183K Sell
4,364
-101
-2% -$4.24K ﹤0.01% 3790
2016
Q1
$181K Buy
4,465
+1,759
+65% +$71.3K ﹤0.01% 3790
2015
Q4
$176K Buy
2,706
+140
+5% +$9.11K ﹤0.01% 3915
2015
Q3
$180K Buy
2,566
+865
+51% +$60.7K ﹤0.01% 3837
2015
Q2
$189K Buy
1,701
+162
+11% +$18K ﹤0.01% 3934
2015
Q1
$145K Buy
1,539
+964
+168% +$90.8K ﹤0.01% 3969
2014
Q4
$65K Sell
575
-9,575
-94% -$1.08M ﹤0.01% 4361
2014
Q3
$623K Buy
10,150
+9,950
+4,975% +$611K ﹤0.01% 2767
2014
Q2
$9K Sell
200
-16,000
-99% -$720K ﹤0.01% 4923
2014
Q1
$634K Buy
+16,200
New +$634K ﹤0.01% 2726
2013
Q4
Sell
-30,270
Closed -$847K 5243
2013
Q3
$847K Buy
+30,270
New +$847K ﹤0.01% 2454